Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect.

Harris, Rodney

doi:10.1136/bmj.280.6225.1199

Cited by 8 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Royal College of Obstetricians and Gynaecologists initially resisted the generalizing of prenatal screening on the grounds that the technology was not foolproof; members feared the prospect of terminating healthy pregnancies following false positives ( Yanchinski, 1978 ). Other clinicians worried that health service planners’ use of prenatal diagnosis and selective termination was overshadowing ‘research into the causes and true prevention of birth defects’ ( Harris, 1980, p. 1199 ). This included studies into the teratogenic properties of new drugs, infectious diseases, synthetic hormones, environmental pollutants, alcohol and smoking.…”

Section: Monitoring Treating and Preventing Ntds After Thalidomidementioning

confidence: 99%

Making birth defects ‘preventable’: Pre-conceptional vitamin supplements and the politics of risk reduction

Al-Gailani

2014

Studies in History and Philosophy of Science Part C: Studies in

View full text Add to dashboard Cite

show abstract

Section: Monitoring Treating and Preventing Ntds After Thalidomidementioning

confidence: 99%

Making birth defects ‘preventable’: Pre-conceptional vitamin supplements and the politics of risk reduction

Al-Gailani

2014

Studies in History and Philosophy of Science Part C: Studies in

View full text Add to dashboard Cite

show abstract

Distress Associated with Prenatal Screening for Fetal Abnormality

2005

View full text Add to dashboard Cite

A theoretically-based, multivariate approach was used to identify factors associated with emotional distress for pregnant women undergoing maternal serum alpha fetoprotein (MSAFP or AFP) testing, used to detect abnormalities of the fetal brain and spinal cord. Participants were those who received normal results (N = 87). Study results supported the hypothesis that different factors would predict distress before and after testing. Satisfaction with information about testing predicted lower emotional distress early in the testing process; concerns about the child having other medical conditions and low-dispositional optimism predicted distress later. Study findings indicate that even in women who receive normal test results, AFP testing is associated with a modest degree of emotional disturbance which declines, but does not completely abate, after testing.

show abstract

The early development of neurosonology: II. Fetal and neonatal echoencephalography

White

1992

Ultrasound in Medicine & Biology

View full text Add to dashboard Cite

Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect.

Cited by 8 publications

References 30 publications

Making birth defects ‘preventable’: Pre-conceptional vitamin supplements and the politics of risk reduction

Making birth defects ‘preventable’: Pre-conceptional vitamin supplements and the politics of risk reduction

Distress Associated with Prenatal Screening for Fetal Abnormality

The early development of neurosonology: II. Fetal and neonatal echoencephalography

Contact Info

Product

Resources

About